Current Concepts in Brain Resuscitation

Jeffrey Kirsch, J. Michael Dean, Mark C. Rogers

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

• In spite of the tremendous amount of effort and money put forth to reduce morbidity and mortality associated with global cerebral ischemia, the outlook for patients suffering an ischemic insult remains dismal. The lack of a sufficient substrate supply during the period of ischemia as well as the production of toxic metabolites in response to ischemia have been incriminated as key factors causing brain damage. As discussed in this article, modes of therapy have included efforts to minimize the duration of ischemia (eg, effective cardiopulmonary resuscitation, hemodilution, heparinization, calcium antagonists) and decrease the production of toxic metabolites (eg, barbiturates, calcium antagonists). Although the barbiturates have also been proposed to decrease the metabolic needs during ischemia, they have no therapeutic value for global cerebral ischemia. The initial evaluation of the calcium antagonists has been more promising.

Original languageEnglish (US)
Pages (from-to)1413-1419
Number of pages7
JournalArchives of Internal Medicine
Volume146
Issue number7
DOIs
StatePublished - 1986
Externally publishedYes

Fingerprint

Resuscitation
Ischemia
Barbiturates
Poisons
Brain
Calcium
Brain Ischemia
Hemodilution
Cardiopulmonary Resuscitation
Morbidity
Mortality
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Current Concepts in Brain Resuscitation. / Kirsch, Jeffrey; Dean, J. Michael; Rogers, Mark C.

In: Archives of Internal Medicine, Vol. 146, No. 7, 1986, p. 1413-1419.

Research output: Contribution to journalArticle

Kirsch, Jeffrey ; Dean, J. Michael ; Rogers, Mark C. / Current Concepts in Brain Resuscitation. In: Archives of Internal Medicine. 1986 ; Vol. 146, No. 7. pp. 1413-1419.
@article{7c93933e77ea438380f440cd6c38b5d9,
title = "Current Concepts in Brain Resuscitation",
abstract = "• In spite of the tremendous amount of effort and money put forth to reduce morbidity and mortality associated with global cerebral ischemia, the outlook for patients suffering an ischemic insult remains dismal. The lack of a sufficient substrate supply during the period of ischemia as well as the production of toxic metabolites in response to ischemia have been incriminated as key factors causing brain damage. As discussed in this article, modes of therapy have included efforts to minimize the duration of ischemia (eg, effective cardiopulmonary resuscitation, hemodilution, heparinization, calcium antagonists) and decrease the production of toxic metabolites (eg, barbiturates, calcium antagonists). Although the barbiturates have also been proposed to decrease the metabolic needs during ischemia, they have no therapeutic value for global cerebral ischemia. The initial evaluation of the calcium antagonists has been more promising.",
author = "Jeffrey Kirsch and Dean, {J. Michael} and Rogers, {Mark C.}",
year = "1986",
doi = "10.1001/archinte.1986.00360190201029",
language = "English (US)",
volume = "146",
pages = "1413--1419",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Current Concepts in Brain Resuscitation

AU - Kirsch, Jeffrey

AU - Dean, J. Michael

AU - Rogers, Mark C.

PY - 1986

Y1 - 1986

N2 - • In spite of the tremendous amount of effort and money put forth to reduce morbidity and mortality associated with global cerebral ischemia, the outlook for patients suffering an ischemic insult remains dismal. The lack of a sufficient substrate supply during the period of ischemia as well as the production of toxic metabolites in response to ischemia have been incriminated as key factors causing brain damage. As discussed in this article, modes of therapy have included efforts to minimize the duration of ischemia (eg, effective cardiopulmonary resuscitation, hemodilution, heparinization, calcium antagonists) and decrease the production of toxic metabolites (eg, barbiturates, calcium antagonists). Although the barbiturates have also been proposed to decrease the metabolic needs during ischemia, they have no therapeutic value for global cerebral ischemia. The initial evaluation of the calcium antagonists has been more promising.

AB - • In spite of the tremendous amount of effort and money put forth to reduce morbidity and mortality associated with global cerebral ischemia, the outlook for patients suffering an ischemic insult remains dismal. The lack of a sufficient substrate supply during the period of ischemia as well as the production of toxic metabolites in response to ischemia have been incriminated as key factors causing brain damage. As discussed in this article, modes of therapy have included efforts to minimize the duration of ischemia (eg, effective cardiopulmonary resuscitation, hemodilution, heparinization, calcium antagonists) and decrease the production of toxic metabolites (eg, barbiturates, calcium antagonists). Although the barbiturates have also been proposed to decrease the metabolic needs during ischemia, they have no therapeutic value for global cerebral ischemia. The initial evaluation of the calcium antagonists has been more promising.

UR - http://www.scopus.com/inward/record.url?scp=0022529759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022529759&partnerID=8YFLogxK

U2 - 10.1001/archinte.1986.00360190201029

DO - 10.1001/archinte.1986.00360190201029

M3 - Article

VL - 146

SP - 1413

EP - 1419

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 7

ER -